These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11709143)

  • 41. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple endobronchial metastases from carcinoma of prostate.
    Lalli C; Gogia H; Raju L
    Urology; 1983 Feb; 21(2):164-5. PubMed ID: 6823724
    [No Abstract]   [Full Text] [Related]  

  • 43. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
    Younes-Mhenni S; Janier MF; Cinotti L; Antoine JC; Tronc F; Cottin V; Ternamian PJ; Trouillas P; Honnorat J
    Brain; 2004 Oct; 127(Pt 10):2331-8. PubMed ID: 15361417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Staging recurrent metastatic colorectal carcinoma with PET.
    Delbeke D; Vitola JV; Sandler MP; Arildsen RC; Powers TA; Wright JK; Chapman WC; Pinson CW
    J Nucl Med; 1997 Aug; 38(8):1196-201. PubMed ID: 9255148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factors for Predicting Occult Lymph Node Metastasis in Patients with Clinical Stage I Non-small Cell Lung Cancer Staged by Integrated Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kaseda K; Asakura K; Kazama A; Ozawa Y
    World J Surg; 2016 Dec; 40(12):2976-2983. PubMed ID: 27456499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma.
    Benyounes H; Smith FW; Campbell C; Evans NT; Norton MY; Mikecz P; Heys SD; Bruce D; Eremin O; Sharp PF
    Nucl Med Commun; 1995 Jul; 16(7):575-80. PubMed ID: 7478396
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer.
    Higashi K; Nishikawa T; Seki H; Oguchi M; Nambu Y; Ueda Y; Yuasa K; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jan; 39(1):9-15. PubMed ID: 9443730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-FDG PET/CT in a patient with lymph node metastasis from ovarian adenocarcinoma.
    Gontier E; Wartski M; Guinebretiere JM; Alberini JL
    AJR Am J Roentgenol; 2006 Sep; 187(3):W285-9. PubMed ID: 16928906
    [No Abstract]   [Full Text] [Related]  

  • 49. An 18-year delay in the clinical presentation of bronchial carcinoid.
    Leuzzi G; Forcella D; Melis E; Visca P; Facciolo F
    Rev Esp Med Nucl Imagen Mol; 2015; 34(5):327-8. PubMed ID: 25630601
    [No Abstract]   [Full Text] [Related]  

  • 50. Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer.
    Nuñez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM
    J Nucl Med; 2002 Jan; 43(1):46-55. PubMed ID: 11801702
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of bone scintigraphy and 18F-FDG PET-CT in a prostate cancer patient with osteolytic bone metastases.
    Ozcan Kara P; Kara T; Kara Gedik G; Sari O; Sahin O
    Rev Esp Med Nucl; 2011; 30(2):94-6. PubMed ID: 21342722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FDG PET/CT imaging in prostate adenocarcinoma presenting as isolated brain metastases of unknown origin.
    Erhamamcı S; Reyhan M; Alkan O
    Rev Esp Med Nucl Imagen Mol; 2015; 34(2):146-7. PubMed ID: 25052407
    [No Abstract]   [Full Text] [Related]  

  • 53. Incidental diagnosis of endometrial carcinoma in a patient with breast cancer by FDG PET/CT.
    Chang CC; Chen YW; Hou MF
    Clin Nucl Med; 2007 Mar; 32(3):205-7. PubMed ID: 17314597
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical and pathological factors related to 18F-FDG-PET positivity in the diagnosis of recurrence and/or metastasis in patients with differentiated thyroid cancer.
    London K; Lin M
    Ann Surg Oncol; 2011 Jan; 18(1):291. PubMed ID: 20505997
    [No Abstract]   [Full Text] [Related]  

  • 55. Fluorodeoxyglucose positron emission tomography scan of prostate cancer bone metastases with flare reaction after endocrine therapy.
    Shimizu N; Masuda H; Yamanaka H; Oriuchi N; Inoue T; Endo K
    J Urol; 1999 Feb; 161(2):608-9. PubMed ID: 9915462
    [No Abstract]   [Full Text] [Related]  

  • 56. [Extension study and evaluation of the therapeutic response in a patient with metastatic lung adenocarcinoma using sequential study with ¹⁸F-FDG PET-CT and ¹⁸F-fluoride PET-CT].
    Moragas M; Soler M; Riera E; García JR
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):45-8. PubMed ID: 24690280
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma.
    Nakata B; Chung YS; Nishimura S; Nishihara T; Sakurai Y; Sawada T; Okamura T; Kawabe J; Ochi H; Sowa M
    Cancer; 1997 Feb; 79(4):695-9. PubMed ID: 9024707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of gall bladder cancer metastases in rare sites by PET scan.
    Shukla PJ; Barreto SG; Shrikhande SV; Mohandas KM; Purandare N; Rangarajan V
    Indian J Gastroenterol; 2007; 26(6):303-4. PubMed ID: 18431025
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluorine-18-fluorodeoxyglucose uptake in pneumonia.
    Kapucu LO; Meltzer CC; Townsend DW; Keenan RJ; Luketich JD
    J Nucl Med; 1998 Jul; 39(7):1267-9. PubMed ID: 9669408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endotracheal Leiomyoma Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Papillary Thyroid Carcinoma.
    Hwang JP; Lee SW; Kwak JJ; Park JM
    Clin Nucl Med; 2017 Sep; 42(9):e403-e404. PubMed ID: 28639955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.